Job Details

Head of Communications and Advocacy, Aruvant Sciences

Location: New York, NY
Department: Roivant Pharma
Posted Date: Nov. 18, 2019
Job Summary

Aruvant Sciences is focused on developing and commercializing gene therapies for hematological diseases utilizing reduced-intensity conditioning.  

 The company's lead candidate, ARU-1801, is an investigational gene therapy for sickle cell disease and β-thalassemia. ARU-1801 utilizes proprietary technology intended to increase functioning red blood cells by inserting a modified fetal hemoglobin gene into autologous stem cells through a lentiviral vector. Studies have indicated that sickle cell patients with elevated levels of fetal hemoglobin have fewer vaso-occlusive crises and hospitalizations, due in part to improved characteristics of fetal hemoglobin relative to adult hemoglobin. ARU-1801 is the only known clinical-stage gene therapy to deliver the gene encoding fetal hemoglobin, which has been modified to optimize oxygen carrying capacity and anti-sickling properties. For more information, please see www.aruvant.com.

Position Title

Head of Communications and Advocacy, Aruvant Sciences

Position Location

Metro New York City

Manager Title

Chief Operating Officer, Aruvant Sciences

Position Summary

 

In this role, you will be responsible for for creating and executing the external communication strategy for Aruvant Sciences. You will lead the public relations strategy, including strategic planning of and execution of all external communications and presentations. You will create and lead Aruvant relationships with key advocacy groups globally. You will be responsible for creating, in collaboration with the executive team, a key opinion leader engagement plan. You will lead the  expansion of Aruvant's online and social media presence.  The Head of Communications and advocacy will work closely with other members of the executive leadership in a highly dynamic, fast-moving environment to create a cohesive external communication strategy for Aruvant.

Responsibilities

·         Create the public relations strategy including determining participation and content for key industry conferences, press releases and other forms of external corporate communication

·         Lead Aruvant relationship with all key patient advocacy groups in Sickle Cell Disease and Beta Thalassemia, to ensure that Aruvant understands patient needs, and advocacy groups understand Aruvant's future goals

·         Develop an organized strategy for ensuring Aruvant stays top of mind with key physician leaders in SCD, Thalassemia and stem cell transplant

·         Develop and execute an online and social media strategy to magnify the reach of Aruvant communications to patients and providers 

Skills, Qualifications, and Requirements

·         10+ years' biopharmaceutical experience, including at least 10 years of direct experience in communications or public relations

·         Track record of developing and executing successful communication strategies for preapproval and/or marketed compounds

·         Experience developing digital communication strategies

·         Experience working with Patient Advocacy Groups

·         Experience with rare diseases preferred

·         Experience with cell or gene therapies preferred

·         Strong writing, presenting and personal communication skills required

·         Able to blend strategic and critical-thinking skills with strong interpersonal skills to both develop strong relationships with external leaders

·         Proven experience handling confidential and sensitive information with the ability to exercise discretion and show good judgment

·         Hands-on, roll-up-your-sleeves approach, with high sense of urgency and drive for results

·         Demonstrated communication, problem-solving, and negotiation/decision-making skills

·         Natural collaborator who enjoys working on a cross-functional team

Working Conditions

·         Dynamic, interactive, fast-paced, and entrepreneurial environment

·         Limited domestic or international travel may be required